Literature DB >> 31320742

Too many people with viral hepatitis are diagnosed late - with dire consequences.

Jeffrey V Lazarus1, Camila Picchio2, John F Dillon3, Jürgen K Rockstroh4, Nina Weis5, Maria Buti6,7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31320742     DOI： 10.1038/s41575-019-0177-z

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.

Authors:  José Luis Calleja; Javier García-Samaniego; Jeffrey V Lazarus; Marcela Villota-Rivas; Inmaculada Fernández; Francisco Gea; Pablo Ryan; Sonia Alonso López; Danielle Guy
Journal:  Commun Med (Lond)       Date:  2022-02-24

2.  Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases.

Authors:  Jingjing Wang; Xin Zhang; Xiaozhen Geng; Juanjuan Shi; Xiaoli Jia; Shuangsuo Dang; Wenjun Wang
Journal:  EClinicalMedicine       Date:  2022-05-05

3.  Progress towards elimination goals for viral hepatitis.

Authors:  Andrea L Cox; Manal H El-Sayed; Jia-Horng Kao; Jeffrey V Lazarus; Maud Lemoine; Anna S Lok; Fabien Zoulim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-23       Impact factor: 46.802

4.  Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?

Authors:  Rosa López-Martínez; Andrea Arias-García; Francisco Rodríguez-Algarra; Laura Castellote-Bellés; Ariadna Rando-Segura; Guillermo Tarraso; Elena Vargas-Accarino; Isabel Montserrat-Lloan; Albert Blanco-Grau; Andrea Caballero-Garralda; Roser Ferrer-Costa; Tomas Pumarola-Sunye; Maria Buti-Ferret; Rafael Esteban-Mur; Josep Quer; Ernesto Casis-Saez; Francisco Rodríguez-Frías
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

5.  Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort.

Authors:  Trevor A Crowell; Haoyu Qian; Carsten Tiemann; Clara Lehmann; Christoph Boesecke; Albrecht Stoehr; Jukka Hartikainen; Stefan Esser; Markus Bickel; Christoph D Spinner; Stephan Schneeweiß; Christiane Cordes; Norbert Brockmeyer; Heiko Jessen; Merlin L Robb; Nelson L Michael; Klaus Jansen; Hendrik Streeck
Journal:  AIDS Res Ther       Date:  2021-08-16       Impact factor: 2.250

6.  Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review.

Authors:  Maria Buti; Jeffrey V Lazarus; Camila A Picchio; Sabela Lens; Manuel Hernandez-Guerra; Juan Arenas; Raúl J Andrade; Javier Crespo; Javier García-Samaniego; Manuel Romero-Gómez; Juan Turnes; José Luis Calleja; Miguel Ángel Simón; Trenton M White; Mar Riveiro-Barciela; Anna Pocurull; Dalia Morales-Arraez; Alexandra Gómez
Journal:  Sci Rep       Date:  2021-12-17       Impact factor: 4.996

7.  The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves.

Authors:  Beatriz Romero-Hernández; Laura Martínez-García; Mario Rodríguez-Dominguez; Javier Martínez-Sanz; Manuel Vélez-Díaz-Pallarés; Belen Pérez Mies; A Muriel; Francisco Gea; María Jesús Pérez-Elías; Juan Carlos Galán
Journal:  Front Public Health       Date:  2022-07-22

8.  Programmable low-cost DNA-based platform for viral RNA detection.

Authors:  Lifeng Zhou; Arun Richard Chandrasekaran; Jibin Abraham Punnoose; Gaston Bonenfant; Stephon Charles; Oksana Levchenko; Pheonah Badu; Cassandra Cavaliere; Cara T Pager; Ken Halvorsen
Journal:  Sci Adv       Date:  2020-09-25       Impact factor: 14.136

9.  Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.

Authors:  Daniel Simões; Annemarie Rinder Stengaard; Lauren Combs; Dorthe Raben
Journal:  Euro Surveill       Date:  2020-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.